These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37023839)

  • 1. Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.
    Xu X; Li Y; Zhang R; Chen X; Shen J; Yuan M; Chen Y; Chen M; Liu S; Wu J; Sun Q
    J Ethnopharmacol; 2023 Jul; 311():116450. PubMed ID: 37023839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
    Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-dependent modulation of pre-metastatic niches by Jianpi Yangzheng decoction in the prevention of lung metastasis of gastric cancer.
    Zhu X; Zhang X; Shen J; Zheng S; Li H; Han B; Zhang C; Chen M; Sun Q; Wu J
    Phytomedicine; 2024 Jun; 128():155413. PubMed ID: 38513377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells.
    Zhang SJ; Feng JF; Wang L; Guo W; Du YW; Ming L; Zhao GQ
    Dig Dis Sci; 2014 Aug; 59(8):1754-63. PubMed ID: 24647998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer.
    Wu J; Zhang XX; Zou X; Wang M; Wang HX; Wang YH; Li CY; Zhao LG; Chen M; Pei LX; Liu SL; Sun QM
    J Ethnopharmacol; 2019 May; 235():56-64. PubMed ID: 30731181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
    Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
    Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
    Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
    Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis.
    Zhou B; Flodby P; Luo J; Castillo DR; Liu Y; Yu FX; McConnell A; Varghese B; Li G; Chimge NO; Sunohara M; Koss MN; Elatre W; Conti P; Liebler JM; Yang C; Marconett CN; Laird-Offringa IA; Minoo P; Guan K; Stripp BR; Crandall ED; Borok Z
    J Clin Invest; 2018 Mar; 128(3):970-984. PubMed ID: 29400695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-767-3p Inhibits Growth and Migration of Lung Adenocarcinoma Cells by Regulating CLDN18.
    Wan YL; Dai HJ; Liu W; Ma HT
    Oncol Res; 2018 May; 26(4):637-644. PubMed ID: 29169410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.
    Rohde C; Yamaguchi R; Mukhina S; Sahin U; Itoh K; Türeci Ö
    Jpn J Clin Oncol; 2019 Sep; 49(9):870-876. PubMed ID: 31087075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
    Song J; Liu Y; Wang T; Li B; Zhang S
    Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
    Zuo QF; Zhang R; Li BS; Zhao YL; Zhuang Y; Yu T; Gong L; Li S; Xiao B; Zou QM
    Cell Death Dis; 2015 Jan; 6(1):e1623. PubMed ID: 25633292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
    Zhang Z; Dai DQ
    World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
    Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
    Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
    Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
    World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ.
    Yuan M; Zou X; Liu S; Xu X; Wang H; Zhu M; Xie X; Wang H; Wu J; Sun Q
    Biomed Pharmacother; 2020 Sep; 129():110440. PubMed ID: 32768942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.